Innovation Showcase

Innovation Showcase Friday lunchtime



This session will discuss the validation and characterisation of a panel of new monoclonal antibodies to defined cell surface proteins found on human pluripotent stem cells. This panel of antibodies is useful for the detection and enrichment of human pluripotent stem cells and can be used to distinguish between naive and primed human pluripotent stem cells. Additionally, the session will cover the Thermo Fisher Scientific Antibody Validation Initiative and using data show the value of using well-validated monoclonal antibodies.

Innovation Showcase: Thermo Fisher Scientific

6/22/2018
11:30 - 12:30

Presented by: Thermo Fisher Scientific 

Presentations:

Andrew Laslett

CSIRO Manufacturing, Victoria, Australia

Associate Professor Andrew Laslett is a Research Team Leader with the CSIRO (Australia), where he leads a human pluripotent stem cell biology research team. He also holds an Adjunct Associate Professor position with the Australian Regenerative Medicine Institute at Monash University. Since 2001, Andrew and his laboratory have focused on elucidating the complex biology of human embryonic stem cells and induced pluripotent stem cells. His laboratory is currently focused on exploiting the basic biology of these cell types to create novel cell lines and tools that enhance human pluripotent cell research translation. He obtained his BSc (Hons) and PhD (1996) from Monash University prior to undertaking postdoctoral positions in both Hong Kong and Philadelphia, USA.

Presentation(s):

Send Email for Andrew Laslett


Assets

Innovation Showcase: VALIDATING ANTIBODIES TO DISTINGUISH BETWEEN NAIVE AND PRIMED HPSCS - Thermo Fisher Scientifc



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Innovation Showcase: VALIDATING ANTIBODIES TO DISTINGUISH BETWEEN NAIVE AND PRIMED HPSCS - Thermo Fisher Scientifc